Education
About Us
Working with TipRanks
Follow Us
SAB Biotherapeutics (SABS)
NASDAQ:SABS
High Dose Sab-142, Low Dose Sab-142
Type 1 Diabetes
Phase II
Not Yet Recruiting
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Sep 08, 2025
―
Sab-176
Influenza A H1n1
Phase II
Completed
Study of SAB-176 in Healthy Adult Participants
Apr 06, 2021
―
Normal Saline, Sab-176
Influenza, Influenza Type A, Influenza Type B
Phase I
Completed
Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants
Jul 10, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does SAB Biotherapeutics (SABS) have in its pipeline
SABS is currently developing the following drugs: High Dose Sab-142, Low Dose Sab-142, Sab-176, Normal Saline, Sab-176. These drug candidates are in various stages of clinical development as the company works toward FDA approval.